Changes in Alzheimer's disease‐associated biomarkers in COVID‐19 patients presenting neurological symptoms
Collectively, our findings put inflammation as a primary correlate of acute and persistent AD-related molecular changes in COVID-19 patients, urging careful follow-up of COVID-19 survivors with lingering inflammation or cognitive symptoms for possible risk of future AD.
Authors
- Bart Vanderborght (ORCID: https://orcid.org/0000-0003-3964-6928)
- Luis Santos
- Felipe Kenji Sudo (ORCID: https://orcid.org/0000-0003-4738-1368)
- Talita P. Pinto (ORCID: https://orcid.org/0000-0002-2461-7203)
- Guilherme B. de Freitas (ORCID: https://orcid.org/0000-0003-4614-4280)
- Nathane Rezende
- Fabiana Souza Lima
- Carlos Otávio Brandão (ORCID: https://orcid.org/0000-0002-4898-5916)
- Fernanda Guarino De Felice
- Fernando A. Bozza
- Fernanda Tovar‐Moll
- Andrea Silveira Souza
- Thaís Lopes Pinheiro
- Paulo E. Mattos
- Fernanda G. Q. Barros‐Aragão
- Gabriel Freitas
- Erika Rodrigues
Institutions
- Queen's University (CA)
- Universidade do Estado do Rio de Janeiro (BR)
- D’Or Institute for Research and Education (BR)
- Fundação Oswaldo Cruz (BR)
Publication Details
- Journal
- Alzheimer s & Dementia
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1002/alz70855_106717
- Primary Topic
- Long-Term Effects of COVID-19
- Type
- article
- Field-Weighted Citation Impact
- 0.00